c.im is one of the many independent Mastodon servers you can use to participate in the fediverse.
C.IM is a general, mainly English-speaking Mastodon instance.

Server stats:

2.9K
active users

#antiviral

3 posts3 participants0 posts today
Giuseppe Michieli<p><a href="https://mstdn.science/tags/Antiviral" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Antiviral</span></a> use and the effects of <a href="https://mstdn.science/tags/drug" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>drug</span></a> <a href="https://mstdn.science/tags/resistance" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>resistance</span></a> on the <a href="https://mstdn.science/tags/transmission" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>transmission</span></a> dynamics of <a href="https://mstdn.science/tags/influenza" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>influenza</span></a>, <a href="https://etidiohnew.blogspot.com/2025/03/antiviral-use-and-effects-of-drug.html" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">etidiohnew.blogspot.com/2025/0</span><span class="invisible">3/antiviral-use-and-effects-of-drug.html</span></a></p>
Bi Sasquatch<p>Source: <span class="h-card" translate="no"><a href="https://bird.makeup/users/seattlegaynews" class="u-url mention">@<span>seattlegaynews</span></a></span> </p><p>From the article: &quot;A bill that would require Medicaid to cover all FDA-approved HIV antivirals has seen early success in the Washington state legislature, most recently being unanimously passed by the Senate&#39;s Health &amp; Long-Term Care Committee meeting on February 13. But with Robert F. Kennedy Jr.&#39;s recent confirmation as the Health and Human Services (HHS) secretary, primary bill sponsor Sen. Marko Liias (D-21) is ready to fight like hell to ensure that Washingtonians have access to this life-saving medication.&quot;</p><p><a href="https://c.im/tags/HIV" class="mention hashtag" rel="tag">#<span>HIV</span></a> <a href="https://c.im/tags/Antiviral" class="mention hashtag" rel="tag">#<span>Antiviral</span></a> <a href="https://c.im/tags/PrEP" class="mention hashtag" rel="tag">#<span>PrEP</span></a> <a href="https://c.im/tags/Washington" class="mention hashtag" rel="tag">#<span>Washington</span></a> <a href="https://c.im/tags/WashingtonState" class="mention hashtag" rel="tag">#<span>WashingtonState</span></a> <a href="https://c.im/tags/Medicaid" class="mention hashtag" rel="tag">#<span>Medicaid</span></a> <a href="https://c.im/tags/Healthcare" class="mention hashtag" rel="tag">#<span>Healthcare</span></a> </p><p><a href="https://www.sgn.org/story.php?ch=news&amp;sc=regional&amp;id=338229" target="_blank" rel="nofollow noopener noreferrer" translate="no"><span class="invisible">https://www.</span><span class="ellipsis">sgn.org/story.php?ch=news&amp;sc=r</span><span class="invisible">egional&amp;id=338229</span></a></p>
Eric's Risk Assessment<p>Ensitrelvir Prevents <a href="https://zeroes.ca/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> Infection as Post Exposure Prophylaxis</p><p>&gt; Japan-based Shionogi presented results for its investigational antiviral, ensitrelvir, that demonstrated a 67% reduction in the risk of developing COVID-19 in uninfected individuals treated after exposure, compared to a placebo at day 10</p><p><a href="https://www.contagionlive.com/view/ensitrelvir-prevents-covid-19-infection-as-post-exposure-prophylaxis" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">contagionlive.com/view/ensitre</span><span class="invisible">lvir-prevents-covid-19-infection-as-post-exposure-prophylaxis</span></a></p><p><a href="https://zeroes.ca/tags/sars2" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>sars2</span></a> <a href="https://zeroes.ca/tags/sarscov2" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>sarscov2</span></a> <a href="https://zeroes.ca/tags/antiviral" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>antiviral</span></a></p>
INBELLA<p>Antiviral: Satire, Sickness, and Celebrity Culture&nbsp; <a href="https://www.inbella.com/947327/antiviral-satire-sickness-and-celebrity-culture/" rel="nofollow noopener noreferrer" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">inbella.com/947327/antiviral-s</span><span class="invisible">atire-sickness-and-celebrity-culture/</span></a> <a href="https://channels.im/tags/antiviral" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>antiviral</span></a> <a href="https://channels.im/tags/BodyHorror" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>BodyHorror</span></a> <a href="https://channels.im/tags/BrandonCronenberg" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>BrandonCronenberg</span></a> <a href="https://channels.im/tags/CelebritiesNews" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CelebritiesNews</span></a> <a href="https://channels.im/tags/horror" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>horror</span></a> <a href="https://channels.im/tags/movies" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>movies</span></a></p>
CellBioNews<p><a href="https://scientificnetwork.de/tags/BREX" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>BREX</span></a> system's unique <a href="https://scientificnetwork.de/tags/DNA_recognition" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>DNA_recognition</span></a> mechanism enhances <a href="https://scientificnetwork.de/tags/bacterial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>bacterial</span></a> <a href="https://scientificnetwork.de/tags/antiviral" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>antiviral</span></a> defense.</p><p><a href="https://scientificnetwork.de/tags/bacteriophages" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>bacteriophages</span></a> <a href="https://scientificnetwork.de/tags/methyltransferase" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>methyltransferase</span></a> </p><p> <a href="https://phys.org/news/2025-03-brex-unique-dna-recognition-mechanism.html" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">phys.org/news/2025-03-brex-uni</span><span class="invisible">que-dna-recognition-mechanism.html</span></a></p>
Giuseppe Michieli<p><a href="https://mstdn.science/tags/Antiviral" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Antiviral</span></a> Susceptibility of <a href="https://mstdn.science/tags/Influenza" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Influenza</span></a> A(<a href="https://mstdn.science/tags/H5N1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>H5N1</span></a>) Clade 2.3.2.1c and 2.3.4.4b Viruses from <a href="https://mstdn.science/tags/Humans" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Humans</span></a>, 2023-2024, <a href="https://etidiohnew.blogspot.com/2025/03/antiviral-susceptibility-of-influenza.html" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">etidiohnew.blogspot.com/2025/0</span><span class="invisible">3/antiviral-susceptibility-of-influenza.html</span></a></p>
Giuseppe Michieli<p>Evaluation of <a href="https://mstdn.science/tags/influenza" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>influenza</span></a> <a href="https://mstdn.science/tags/antiviral" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>antiviral</span></a> <a href="https://mstdn.science/tags/prophylaxis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>prophylaxis</span></a> for long-term care residents: a systematic review and meta-analysis, <a href="https://etidiohnew.blogspot.com/2025/03/evaluation-of-influenza-antiviral.html" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">etidiohnew.blogspot.com/2025/0</span><span class="invisible">3/evaluation-of-influenza-antiviral.html</span></a></p>
Giuseppe Michieli<p>Role of <a href="https://mstdn.science/tags/antiviral" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>antiviral</span></a> <a href="https://mstdn.science/tags/CD8" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CD8</span></a>+ T cell <a href="https://mstdn.science/tags/immunity" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>immunity</span></a> to <a href="https://mstdn.science/tags/SARS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>SARS</span></a>-CoV-2 <a href="https://mstdn.science/tags/infection" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>infection</span></a> and <a href="https://mstdn.science/tags/vaccination" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>vaccination</span></a>, <a href="https://etidiohnew.blogspot.com/2025/03/role-of-antiviral-cd8-t-cell-immunity.html" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">etidiohnew.blogspot.com/2025/0</span><span class="invisible">3/role-of-antiviral-cd8-t-cell-immunity.html</span></a></p>
Giuseppe Michieli<p><a href="https://mstdn.science/tags/Antiviral" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Antiviral</span></a> Mechanisms and <a href="https://mstdn.science/tags/Preclinical" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Preclinical</span></a> Evaluation of <a href="https://mstdn.science/tags/Amantadine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Amantadine</span></a> <a href="https://mstdn.science/tags/Analogs" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Analogs</span></a> that Continue to Inhibit <a href="https://mstdn.science/tags/Influenza" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Influenza</span></a> A Viruses with M2S31N-Based Drug Resistance, <a href="https://etidiohnew.blogspot.com/2025/02/antiviral-mechanisms-and-preclinical.html" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">etidiohnew.blogspot.com/2025/0</span><span class="invisible">2/antiviral-mechanisms-and-preclinical.html</span></a></p>
Giuseppe Michieli<p><a href="https://mstdn.science/tags/USA" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>USA</span></a>, <a href="https://mstdn.science/tags/Flu" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Flu</span></a> <a href="https://mstdn.science/tags/Antiviral" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Antiviral</span></a> Drugs <a href="https://mstdn.science/tags/Resistance" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Resistance</span></a>: Two A <a href="https://mstdn.science/tags/H1N1pdm09" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>H1N1pdm09</span></a> viruses had NA-H275Y amino acid substitution conferring highly reduced <a href="https://mstdn.science/tags/inhibition" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>inhibition</span></a> by <a href="https://mstdn.science/tags/oseltamivir" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>oseltamivir</span></a> and <a href="https://mstdn.science/tags/peramivir" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>peramivir</span></a>. One A <a href="https://mstdn.science/tags/H1N1pdm09" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>H1N1pdm09</span></a> virus had NA-I223V and NA-S247N amino acid substitutions and showed reduced inhibition by <a href="https://mstdn.science/tags/oseltamivir" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>oseltamivir</span></a>. FluView: <a href="https://www.cdc.gov/fluview/surveillance/2025-week-05.html" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">cdc.gov/fluview/surveillance/2</span><span class="invisible">025-week-05.html</span></a></p>
David August<p>The Zorya Anti-Phage Defense System sounds like a hardcore sci-fi missile defense deployed by the Xanthan Conglomerate over their Ytterbium mines. It isn’t, but it kinda sounds like it is. </p><p><a href="https://phys.org/news/2025-01-bacteria-anti-missile-defense-fend.html" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">phys.org/news/2025-01-bacteria</span><span class="invisible">-anti-missile-defense-fend.html</span></a> </p><p><a href="https://mastodon.online/tags/bacteria" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>bacteria</span></a> <a href="https://mastodon.online/tags/phage" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>phage</span></a> <a href="https://mastodon.online/tags/scifi" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>scifi</span></a> <a href="https://mastodon.online/tags/medicine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>medicine</span></a> <a href="https://mastodon.online/tags/biology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>biology</span></a> <a href="https://mastodon.online/tags/antiviral" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>antiviral</span></a></p>
DoomsdaysCW<p>But yes, it's <a href="https://kolektiva.social/tags/BusinessAsUsual" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>BusinessAsUsual</span></a> because <a href="https://kolektiva.social/tags/Crapitalism" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Crapitalism</span></a> requires people to <a href="https://kolektiva.social/tags/ConsumeConsumeConsume" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ConsumeConsumeConsume</span></a>!</p><p>Canadian teen with <a href="https://kolektiva.social/tags/BirdFlu" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>BirdFlu</span></a> was on <a href="https://kolektiva.social/tags/LifeSupport" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LifeSupport</span></a>, new report reveals</p><p>The hospitalized teen was also given three <a href="https://kolektiva.social/tags/antiviral" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>antiviral</span></a> treatments, underscoring how severe <a href="https://kolektiva.social/tags/H5N1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>H5N1</span></a> infection can be</p><p>By Nicole Karlis, January 6, 2025</p><p>"In November, a teenager in British Columbia was infected and hospitalized with bird flu, caused by the H5N1 virus. While most cases have been mild, commonly characterized by <a href="https://kolektiva.social/tags/conjunctivitis" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>conjunctivitis</span></a> and respiratory symptoms, this previously healthy Canadian teen was hospitalized from the virus in critical condition. Their symptoms started with double conjunctivitis, also known as pink eye, and turned into a fever and coughing. A few days later the teenager was admitted to intensive care after developing acute respiratory distress syndrome [<a href="https://kolektiva.social/tags/ARDS" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ARDS</span></a>].</p><p>"'This was a healthy teenager prior to this, so no underlying conditions,' said British Columbia’s health officer, Bonnie Henry, at a news conference at the time. 'It just reminds us that in young people this is a virus that can progress and cause quite severe illness.'</p><p>"Now, a recent report brings to light more details about the teenager’s case. In the report, published in the New England Journal of Medicine (NEJM), researchers explain that the 13-year-old girl spent weeks fighting for her life after contracting a severe H5N1 infection from an unknown source. In finding her diagnosis, researchers say that she initially tested positive for influenza A, but not the seasonal subtype. Further testing suggested she had a high viral load of a novel influenza A infection, which researchers discovered to be the H5N1 avian flu.</p><p>"The next day doctors started her on oseltamivir, also known under the brand name Tamiflu. However, her respiratory functions declined rapidly causing her to be intubated. She was also placed on extracorporeal membrane oxygenation (ECMO), a machine that is a form of life support for people with life-threatening illnesses. In addition to the ECMO machine, the teenager received a plasma exchange and two more antiviral medication treatments — amantadine and baloxavir. </p><p>"In an accompanying editorial, experts noted while mutations were detected in her case, it’s 'unclear whether these <a href="https://kolektiva.social/tags/mutations" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>mutations</span></a> were present in the infecting virus or emerged during the course of the patient’s illness.'</p><p>"In other words, it’s unclear if the virus <a href="https://kolektiva.social/tags/mutated" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>mutated</span></a> to be more severe in humans.</p><p>"'The mutations evident in the Canadian case highlight the urgent need for vigilant surveillance of emerging mutations and assessment of the threat of human-to-human transmission,' the editorial stated, adding that vaccine development and therapeutics are also needed — perhaps to treat more severe illness. 'The Canadian case showed higher viral loads in the lower airway and very prolonged shedding, despite therapy, which highlights the potential need for longer therapy.'</p><p>"Researchers concluded their editorial with an acknowledgment that 'many questions remain.' For example, the severity of cases is likely to depend on host immunity, the route of exposure, or other changes in the virus. </p><p>"Currently, the CDC says that the risk to most Americans remains low. </p><p>"'We do have candidate vaccines and antivirals available to try to mitigate severe influenza in the case of wider spread,' the report stated. 'That said, a balance between enhanced vigilance and ‘business as usual’ is needed."</p><p><a href="https://www.salon.com/2025/01/06/new-report-on-severe-case-of-canadian-teen-with-bird-flu/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">salon.com/2025/01/06/new-repor</span><span class="invisible">t-on-severe-case-of-canadian-teen-with-bird-flu/</span></a><br><a href="https://kolektiva.social/tags/HPAI" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>HPAI</span></a> <a href="https://kolektiva.social/tags/BirdFluMutations" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>BirdFluMutations</span></a> <a href="https://kolektiva.social/tags/Flu" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Flu</span></a></p>
Zoomers of the Sunshine Coast<p>HELIOX: WHERE EVIDENCE MEETS EMPATHY • DEC 30, 2024 </p><p>Novel Antiviral Targets <br>Viral Methyltransferases</p><p>A new class of antiviral drugs that target viral methyltransferases. Moving beyond familiar treatments like Paxlovid, they discuss how these novel antivirals could potentially combat a wide range of viruses, from COVID-19 to Ebola and dengue. </p><p>COVID-19 &amp; Public Health Podcasts <br><a href="https://www.buzzsprout.com/240578" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="">buzzsprout.com/240578</span><span class="invisible"></span></a></p><p><a href="https://mstdn.ca/tags/ViralMethyltransferases" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ViralMethyltransferases</span></a> <a href="https://mstdn.ca/tags/AntiViral" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AntiViral</span></a> <a href="https://mstdn.ca/tags/HelioxPodcast" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>HelioxPodcast</span></a> </p><p><a href="https://www.buzzsprout.com/2405788/episodes/16349568" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">buzzsprout.com/2405788/episode</span><span class="invisible">s/16349568</span></a></p>
Kim Perales<p>Potential life-saving healthcare news:</p><p>Scientists have pioneered antivirals targeting Covid, Ebola… offering a new strategy for treating RNA &amp; DNA viruses. </p><p><a href="https://toad.social/tags/Healthcare" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Healthcare</span></a> <a href="https://toad.social/tags/Antiviral" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Antiviral</span></a> <a href="https://toad.social/tags/Medicine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Medicine</span></a> <a href="https://toad.social/tags/Covid" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Covid</span></a> <a href="https://scitechdaily.com/beyond-paxlovid-scientists-unveil-game-changing-antiviral-that-could-combat-covid-ebola-and-more/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">scitechdaily.com/beyond-paxlov</span><span class="invisible">id-scientists-unveil-game-changing-antiviral-that-could-combat-covid-ebola-and-more/</span></a></p>
Luke Parrish<p>On <a href="https://c.im/tags/Mastodon" class="mention hashtag" rel="tag">#<span>Mastodon</span></a> you are less likely to get an immediate response, but more likely to get one days later than on <a href="https://c.im/tags/Twitter" class="mention hashtag" rel="tag">#<span>Twitter</span></a>. Feature, not bug! <a href="https://c.im/tags/antiviral" class="mention hashtag" rel="tag">#<span>antiviral</span></a></p>